Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome (NCT07498998) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome
Egypt105 participantsStarted 2026-07-30
Plain-language summary
This study aims to compare the efficacy and outcomes of perineural injection with 5% dextrose, local ozone and glucocorticoid injection in the management of carpal tunnel syndrome.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18-65 years with a clinical diagnosis of mild to moderate Carpal Tunnel Syndrome .
* Clinical diagnosis of mild to moderate Carpal Tunnel Syndrome , as classified by Bland neurophysiological classification scale: Mild Carpal Tunnel Syndrome : Slow Distal Sensory Latency(≥3.6 ms), Normal Distal Motor Latency(\< 4.5 ms)
* Moderate Carpal Tunnel Syndrome : Slow Distal Sensory Latency (≥ 3.6 ms), Slow Distal Motor Latency (4.5 - 6.4 ms)
* Failure to respond to conservative treatments (e.g., splinting, activity modification, or oral medications) for at least 6 weeks.
Exclusion Criteria:
* Patient refusal.
* Severe Carpal Tunnel Syndrome requiring surgical intervention, as defined by the Bland neurophysiological classification scale: Severe Carpal Tunnel Syndrome: Absent Distal Sensory Latency and Slow Distal Motor Latency (4.5 - 6.4 ms)
* Previous corticosteroid injection for Carpal Tunnel Syndrome within the last 6 months.
* History of wrist trauma, surgery or anatomical abnormalities.
* Systemic conditions such as diabetes mellitus, thyroid dysfunction or rheumatoid arthritis.
* Pregnancy or lactation.
* Contraindications to any of the study interventions (e.g., allergy to glucocorticoids or ozone).
* Infection at wrist.